Pilgrim’s Pride pays $108M in price-fixing scandal
By 
Jaclyn Jaeger2021-03-01T21:00:00
Pilgrim’s Pride has become the first company to plead guilty for its role in a conspiracy to fix prices and rig bids in the broiler chicken industry and will pay a $108 million criminal fine.
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
ArticleJBS USA names global head of legal and compliance
JBS USA has named Kevin Arquit to the newly created role of chief legal officer. Arquit will be responsible for leading the company’s global legal, ethics, and compliance efforts.
-
ArticleBrazilian meatpacker’s FCPA settlement details widespread corruption
Brazilian company JBS, the largest meat producer in the world, and its holding company agreed to pay nearly $300 million for systemic and widespread corruption in settlements with two U.S. enforcement agencies.
-
ArticleFormer Bumble Bee CEO sentenced 40 months for price-fixing
The former CEO and president of Bumble Bee Foods was sentenced to serve 40 months in prison and pay a $100,000 criminal fine for playing a leading role in a three-year antitrust conspiracy to fix prices of canned tuna.
More from Regulatory Enforcement
-
ArticleFrench investigators target anticompetitive practices in largest accounting firms
Major accountancy firms in France are under investigation for anti-competitive practices. The French competition watchdog embarked on a series of “unannounced inspections” and removed documents relating to audit and reporting on Jan. 13.
-
ArticleEU investigation into Grok may expose problems with DSA rather than compliance failings
The European Commission has launched a formal investigation against Elon Musk’s X under the Digital Services Act over fears that its AI tool Grok may be producing and disseminating illegal material.
-
ArticleFormer ADM execs inflated operating profits, SEC alleges
Three former executives at Archer-Daniels-Midland intentionally misled investors by inflating the performance of the company’s Nutrition unit, the U.S. Securities and Exchange Commission has alleged.